These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 901665)

  • 1. [Pharmacological study of parkinsonian tremor. II. Role of the dopamine-acetylcholine system].
    Cerone G; Ruggieri S; Aloisi P; Cappenberg L; Agnoli A
    Boll Soc Ital Biol Sper; 1977 Mar; 53(5):349-53. PubMed ID: 901665
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological study of parkinsonian tremor. I. Methods].
    Ruggieri S; Cerone G; Aloisi P; Cappenberg L; Agnoli A
    Boll Soc Ital Biol Sper; 1977 Mar; 53(5):344-8. PubMed ID: 20117
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological study of parkinsonian tremor. III. Role of the serotonin-histamine system].
    Cerone G; Ruggieri S; Aloisi P; Cappenberg L; Agnoli A
    Boll Soc Ital Biol Sper; 1977 Mar; 53(5):354-60. PubMed ID: 901666
    [No Abstract]   [Full Text] [Related]  

  • 4. Parkinsonian tremor: a neuropharmacological study.
    Cerone G; Ruggieri S; Agnoli A
    Acta Neurol Belg; 1977; 77(4):213-29. PubMed ID: 20729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
    Friedhoff AJ; Alpert M
    Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131
    [No Abstract]   [Full Text] [Related]  

  • 6. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
    Altagracia M; Rojas P; Kravzov J; Rios C
    Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas.
    Bartholini G; Stadler H; Ciria MG; Lloyd KG
    Neuropharmacology; 1976 Sep; 15(9):515-9. PubMed ID: 980227
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinsonism induced by dopaminergic antagonists.
    Hornykiewicz O
    Adv Neurol; 1975; 9():155-64. PubMed ID: 1096571
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of phenothiazines on central cholinergic activity.
    Van Woert MH; Sethy VH; Ambani LM
    Adv Biochem Psychopharmacol; 1974; 9(0):707-15. PubMed ID: 4151771
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Parkinson syndrome].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111. PubMed ID: 4773983
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolism of dopamine and norepinephrine in rat brain after acute and chronic administration of haloperidol, loxapine and clozapine].
    Bürki HR
    Arzneimittelforschung; 1974 Jul; 24(7):983-4. PubMed ID: 4136404
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopaminergic regulation of cholinergic neurons in the striatum: relation to Parkinsonism.
    Bartholini G; Lloyd KG; Stadler H
    Adv Neurol; 1974; 5():11-4. PubMed ID: 4440567
    [No Abstract]   [Full Text] [Related]  

  • 13. [Improved perseveration with amantadine].
    Imamura T; Suzuki K; Yamadori A; Sahara M; Nagasawa H; Itoh M; Itoh H
    No To Shinkei; 1994 Jun; 46(6):556-62. PubMed ID: 8068438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and acetylcholine release in thalamus of non-parkinsonian and parkinsonian subjects.
    Malais P; Waltregny A; Maula A; Dresse A
    Acta Neurol Belg; 1990; 90(4):200-6. PubMed ID: 2124030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    J Neural Transm Suppl; 1986; 20():41-6. PubMed ID: 3462325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the Soviet preparation midantan in the treatment of the Parkinsonian syndrome].
    Balunov OA; Bazhin EF; Morozova ES; Fedotenkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1178-81. PubMed ID: 4417237
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. IV. Antiadrenergic action and influence on brain monoamines.
    Dlabac A; Metys J; Metysová J
    Act Nerv Super (Praha); 1971; 13(3):188-9. PubMed ID: 5113833
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
    Rinne UK; Sonninen V; Marttila R
    Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of liposomal form of L-Dopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome].
    Iurasov VV; Podgornyĭ GI; Kucherianu VG; Kudrin VS; Nikushkin EV; Zhigal'tsev IV; Sandalov IuG; Kaplun AP; Shvets VI; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1996 Dec; 122(12):614-7. PubMed ID: 9280455
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of the system of reverse capture of dopamine in the development of experimental Parkinsonism under the effect of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its pyridine analogs].
    Bachurin SO; Soliakov LS; Lermontova NN; Tkachenko SE; Kalashnikov VV; Serkova TP; Petrova LN
    Dokl Akad Nauk SSSR; 1989; 307(3):740-3. PubMed ID: 2806070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.